Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti‐CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Trial
Article in Arthritis & Rheumatology (August 2023)
The most recent citing publications are shown below. View all 113 publications that cite this research output on Dimensions.
Article in Arthritis & Rheumatology (August 2023)
Article in Journal of Pharmaceutical Health Care and Sciences (January 2023)
Article in Biomedicines (November 2022)